When it comes to liver disease, early intervention isn’t just helpful, it’s critical. Known as the body’s “silent organ,” the liver can endure years of damage before symptoms become visible. By the time fatigue, abdominal pain, or jaundice appear, a patient may already be in advanced stages of fibrosis or cirrhosis, making treatment more difficult, expensive, and often less effective.
Globally, liver diseases like Non-Alcoholic Fatty Liver Disease (NAFLD) and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) are on the rise, affecting nearly one in three adults. These conditions often remain undiagnosed until significant liver damage has already occurred, largely because current diagnostic tools like liver biopsies or elastography are either invasive, expensive, or inaccessible in primary care settings.
Why Early Detection Matters?
Clinical studies show that early-stage liver disease is reversible with lifestyle modifications, medication, and regular monitoring. But once it progresses to cirrhosis, options become limited, and the risk of complications like liver cancer or transplantation rises sharply.
That’s where Fibronostics makes a difference.
Fibronostics tools are empowering primary care providers, specialists, and health systems worldwide to act earlier, faster, and smarter. Let’s move liver care upstream. By catching disease in its silent phase, we not only improve patient outcomes but also save lives.
Transforming Liver Care with AI-Powered Diagnostics
At Fibronostics, we’re transforming how liver disease is detected and managed. Our flagship diagnostic tool, LIVERFASt™, leverages artificial intelligence and a simple blood sample to assess key liver metrics — fibrosis, steatosis, and inflammation — in a non-invasive, scalable, and cost-effective way. Results are generated in minutes, helping clinicians:
-
Detect liver damage before symptoms appear
-
Identify at-risk patients early in the care journey
-
Track disease progression or regression over time
-
Make timely, informed clinical decisions
This approach shifts the paradigm from reactive treatment to proactive prevention, enabling earlier interventions that can slow, halt, or even reverse disease progression.
